Skip to main content
Caplight Logo









Bionomous

Bionomous

Private
Villaz-Saint-PierreHealthcare & Life Scienceshttps://bionomous.ch/

Last Round

Series A

Jan 20, 2023

Total Funding Raised

$4.39M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bionomous is a life sciences technology company that provides automated, AI-powered solutions for the screening, sorting, and plating of small biological entities.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Devices, Biotechnology, Computer Vision, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

automated sortingbiological entity sortinglab automationcomputer visionmicrofluidicshigh-throughput screeningzebrafish embryo sortingdrug discovery toolsbiotech equipmentautomated dispensinglaboratory roboticsbenchtop automationimage processing softwarecontract research organizationCROliquid handling

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bionomous Comparables

Compare Bionomous with similar companies based on industry and business-model similarity.

Bionomous comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nagi Bioscience SA
83%
Union Biometrica, Inc.
81%
Phylumtech S.A.
78%

Bionomous Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 20, 2023
SeedSep 9, 2021
GrantNov 20, 2020
DebtJan 28, 2020

Key People

Founding team and executive leadership

Frank Bonnet

CEO Co-founder

Founding Team

Bionomous Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 44% MoM.

  • Apr 8, 2025

    Raghu Behara appointed to lead commercial strategy and partnerships.

Bionomous Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bionomous Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bionomous's valuation, stock price, and market status.

Firmographic Details

HeadquartersVillaz-Saint-Pierre
Employee Range13
Year Founded2019
Last FundingJan 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?